Indore

ANTI-ANEMIC ACTIVITY OF HYDRO-ALCOHOLIC EXTRACT OF FRUIT OF ALLIUM TRICOCCUM IN PHENYLHYDRAZINE INDUCED ANEMIC RATS

{ DOWNLOAD AS PDF }

PhotoABOUT AUTHORS
DEEPANSHU GUPTA *, CHANDRAKANTA KUSHWAH , ANKUR JOSHI , SAPNA MALVIYA & ANIL KHARIA
Department of pharmacy
Modern institute of Pharmaceutical Sciences, (Shri Prabhat Chandra Kharia Research and Educational Society)
Indore, M.P, India

*guptadeepanshu252@gmail.com

ABSTRACT
This current research was done to bring out the anti-anemic activity in hydro-alcoholic extract of fruit of Allium tricoccum in phenylhydrazine induced anemic rats. The anemia was induced by the administration of Phenylhydrazine (60mg/kg) intraperitoneally in rats for two days. The animals were divided into 5 groups containing 6 animals each. 1st group was served as normal control group, 2nd group was served as anemic control, 3rd group was served as standard reference control administered with Vit. B12 complex, 4th group was served as test control-I administered with 100mg/kg of hydro-alcoholic extract of fruit of Allium tricoccum and 5th group was served as test control-II administered with 200mg/kg of hydro-alcoholic extract of fruit of Allium tricoccum. All the test drugs were given for 28 days daily through oral route. On 29th day blood was withdrawn, through tail puncture and subjected to the estimation of RBC, Hb and percentage Haematocrit. Both the hydro-alcoholic fruit extract of Allium tricoccum and Vit. B12 significantly increase the Haemoglobin, Red Blood Cells & percentage Haematocrit level which conclude that Allium tricoccum fruit exhibits’ the anti-anemic activity.

Recruitment for Assistant Professor/ Lecturer at Chordia Institute of Pharmacy | 06 posts

Chordia Institute of Pharmacy is approved by All India Council of Technical Education (AICTE), Delhi and affiliated to Rajiv Gandhi proudyogiki Vishwavidalaya (M.P) and also approved from Pharmacy Council of India (PCI). The College was Established in 2007.

Post : Assistant Professor/ Lecturer

Vacancy for M.Pharm, B.Pharm, M.Sc in Quality Control, ADL, Production, Warehouse at Ipca Laboratories

Ipca has been partnering healthcare globally in over 110 countries and in markets as diverse as Africa, Asia, Australia, Europe and the US. Ipca is a fully-integrated Indian pharmaceutical company manufacturing over 350 formulations and 80 APIs for various therapeutic segments. We are one of the world's largest manufacturers and suppliers of over a dozen APIs. These are produced right from the basic stage at manufacturing facilities endorsed by the world's most discerning drug regulatory authorities like US-FDA, UK-MHRA, EDQM-Europe, WHO-Geneva and many more. Ipca is a therapy leader in India for anti-malarials with a market-share of over 34% with a fast expanding presence in the international market as well.

Recruitment for Pharmacists (26 posts) at 1MG Technologies | walk in

1mg is India’s leading consumer health platform with over 3 Million downloads. It aspires to be the trusted health partner for all Indians and its mission is to make healthcare accessible, understandable and affordable for a billion Indians. It enables consumers to learn more about their medicines and also find more cost-effective substitutes. 1mg’s doctor platform aims to revolutionize how a consumer finds the right healthcare professional for his needs. It’s recently launched diagnostics service brings transparency and price-effectiveness to lab tests. 1mg is an initiative taken in the spirit of public service with a vision to empower Indian consumers and caregivers to select the most appropriate healthcare service at the best possible price.

Post : Pharmacist

Walk in interview for M.Pharm, B.Pharm, M.Sc in Quality Control, Quality Assurance, Production, ADL, R&D at IPCA Lab

IPCA now plus Rs.2700 Crores Company is global player with significant presence in over 110 countries with high brand equity in the domestic and international markets Our manufacturing facilities of bulk drugs at Ratlam have earned accreditations and approvals from the worlds most vigilant regulatory bodies.

Walk in interview in Quality Control, Quality Assurance, Production, Microbiology at Glenmark

Glenmark is a leading player in the discovery of new molecules both NCEs (new chemical entity) and NBEs (new biological entity) with eight molecules in various stages of clinical development. The company has a significant presence in branded generics markets across emerging economies including India. Its subsidiary, Glenmark Generics Limited has a fast growing and robust US generics business. The subsidiary also markets APIs to regulated and semi-regulated countries. Glenmark employs nearly 6000 people in over 80 countries. It has twelve manufacturing facilities in four countries and has five R&D centres.

Walk in interview for M.Pharm, M.Sc, B.Pharm in Quality Control, Quality Assurance, Production & Packing at Alembic Limited

Alembic Limited, with an established presence in the Indian pharma  industry has a proud, historical track record going back one hundred years. With a turnover in excess of Rs1000 crores today, Alembic Limited is one of India’s leading integrated pharmaceutical companies. We continue to enjoy leadership positions in antibiotics, anti-infective, anti-cough and also have significant worldwide presence in specialty therapeutic areas such as cardiology, neurology, diabetology, etc. We have also plans for expansion in Ophthalmic etc.

Walk in interview in Quality Control, Packing, Tablet, Capsule Manufacturing, Stores at Cipla

Cipla known for its innovative pharmaceutical products backed by latest in technology and creative marketing practices, is enjoying a commanding position among the top pharma companies in the country. Several specialised therapeutic divisions and promising new products have been launched and many more are in the pipeline.

Walk in interview for M.Pharm, M.Sc, B.Pharm in Quality Control, Quality Assurance at Piramal Enterprises

The flagship company of the Piramal Group, Piramal Enterprises Ltd. (PEL), has business interests in Pharma, Information Management, and Financial Services verticals of the group.  Towards the late 80s, we shifted our focus from textile to pharmaceuticals. We chose to invest significantly in the domestic formulation development business, while other companies in the industry concentrated on international generics. Our efforts proved successful with a track record of approximately 23% revenue CAGR. In 2010, our strategy accomplished a sale of its domestic formulations business at an unprecedented value of ~9x sales and ~30x EBITDA.

Pages